Cargando…

Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease

INTRODUCTION: The clinical features of Alzheimer’s disease (AD) overlap with a number of other dementias and conclusive diagnosis is only achieved at autopsy. Accurate in-life diagnosis requires finding biomarkers suitable for early diagnosis, as well as for discrimination from other types of dement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteras, Noemí, Alquézar, Carolina, de la Encarnación, Ana, Villarejo, Alberto, Bermejo-Pareja, Félix, Martín-Requero, Ángeles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978675/ https://www.ncbi.nlm.nih.gov/pubmed/24499616 http://dx.doi.org/10.1186/alzrt219

Ejemplares similares

Familial Alzheimer’s Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants
por: Wojsiat, Joanna, et al.
Publicado: (2016)

Inactivation of CDK/pRb Pathway Normalizes Survival Pattern of Lymphoblasts Expressing the FTLD-Progranulin Mutation c.709-1G>A
por: Alquezar, Carolina, et al.
Publicado: (2012)

Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions
por: Rodríguez-Periñán, Guiomar, et al.
Publicado: (2023)

Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer’s disease mortality
por: Benito-León, Julián, et al.
Publicado: (2019)

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
por: Bermejo-Pareja, Felix, et al.
Publicado: (2010)

Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia
por: Alquezar, Carolina, et al.
Publicado: (2016)

Role of Resveratrol and Selenium on Oxidative Stress and Expression of Antioxidant and Anti-Aging Genes in Immortalized Lymphocytes from Alzheimer’s Disease Patients
por: Cosín-Tomàs, Marta, et al.
Publicado: (2019)

Calmodulin Binding Proteins and Alzheimer’s Disease: Biomarkers, Regulatory Enzymes and Receptors That Are Regulated by Calmodulin
por: O’Day, Danton H.
Publicado: (2020)

Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions
por: Bermejo‐Pareja, Félix, et al.
Publicado: (2020)

Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin
por: Carro, Eva, et al.
Publicado: (2017)

High education accelerates cognitive decline in dementia: A brief report from the population-based NEDICES cohort
por: Contador, Israel, et al.
Publicado: (2017)

TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer’s Disease Patients
por: Cuevas, Eva P., et al.
Publicado: (2022)

Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer’s Disease Patients
por: Spuch, Carlos, et al.
Publicado: (2015)

Calmodulin Binding Proteins and Alzheimer’s Disease
por: O’Day, Danton H., et al.
Publicado: (2015)

Physical activity and long-term mortality risk in older adults: A prospective population based study (NEDICES)
por: Llamas-Velasco, Sara, et al.
Publicado: (2016)

Phytochemical Interactions with Calmodulin and Critical Calmodulin Binding Proteins Involved in Amyloidogenesis in Alzheimer’s Disease
por: O’Day, Danton H.
Publicado: (2023)

A review of the potential therapeutic role of statins in the treatment of Alzheimer’s disease: current research and opinion
por: Sánchez-Ferro, Álvaro, et al.
Publicado: (2013)

Physical activity and risk of Parkinson’s disease and parkinsonism in a prospective population-based study (NEDICES)
por: Llamas-Velasco, Sara, et al.
Publicado: (2021)

Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
por: Ghosh, Anshua, et al.
Publicado: (2015)

Alzheimer's Disease: A short introduction to the calmodulin hypothesis
por: O'Day, Danton H.
Publicado: (2019)

Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates
por: Bartolome, Fernando, et al.
Publicado: (2018)

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates
por: Bartolome, Fernando, et al.
Publicado: (2017)

The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer’s Disease
por: Poejo, Joana, et al.
Publicado: (2021)

Restoration of Calmodulin-Like Skin Protein as Treatment for Alzheimer's Disease
por: Matsuoka, Masaaki
Publicado: (2021)

Neurología clínica básica
por: Bermejo Pareja, Félix
Publicado: (1991)

Effects of changes in calmodulin levels on cell proliferation.
por: Rasmusen, C D, et al.
Publicado: (1990)

Pivoting between Calmodulin Lobes Triggered by Calcium in the Kv7.2/Calmodulin Complex
por: Alaimo, Alessandro, et al.
Publicado: (2014)

Calmodulin and Calmodulin Binding Proteins in Dictyostelium: A Primer
por: O’Day, Danton H., et al.
Publicado: (2020)

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients
por: Martinez-Gonzalez, Loreto, et al.
Publicado: (2023)

Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease
por: Sánchez-Campillo, María, et al.
Publicado: (2019)

Loss of Ca(2+)/Calmodulin Dependent Protein Kinase Kinase 2 Leads to Aberrant Transferrin Phosphorylation and Trafficking: A Potential Biomarker for Alzheimer's Disease
por: Sabbir, Mohammad Golam
Publicado: (2018)

Neuronal calmodulin levels are controlled by CAMTA transcription factors
por: Vuong-Brender, Thanh Thi, et al.
Publicado: (2021)

Calmodulin-dependent and calmodulin-independent glutamate decarboxylases in apple fruit
por: Trobacher, Christopher P, et al.
Publicado: (2013)

The role of calmodulin and calmodulin-dependent protein kinases in the pathogenesis of atherosclerosis
por: Chen, Mei-Fang
Publicado: (2021)

Alzheimer’s Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression
por: O’Day, Danton H.
Publicado: (2023)

Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014)

Blood Biomarkers in Alzheimer’s Disease
por: Mandal, Pravat K., et al.
Publicado: (2023)

Purification of calmodulin from Chlamydomonas: calmodulin occurs in cell bodies and flagella
Publicado: (1980)

Human Calmodulin Methyltransferase: Expression, Activity on Calmodulin, and Hsp90 Dependence
por: Magen, Sophia, et al.
Publicado: (2012)

Involvement of calmodulin and calmodulin-like proteins in plant responses to abiotic stresses
por: Zeng, Houqing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_smpj3846vm6760ag8pqfn7o0s8